Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 26 Issue 3
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2008  >  (3): 175-177,190

XU Yong, HUANG Xiao-jin, XU Jian-ming, CAI Ling-zhi, SONG Yan, ZHAO Qing-jie, Wu Qiu-ye. Synthesis and the antiplatelet aggregative activity of 4,5-dihydro-3(2 H)-pyridazinones[J]. Journal of Pharmaceutical Practice and Service, 2008, (3): 175-177,190.
Citation: XU Yong, HUANG Xiao-jin, XU Jian-ming, CAI Ling-zhi, SONG Yan, ZHAO Qing-jie, Wu Qiu-ye. Synthesis and the antiplatelet aggregative activity of 4,5-dihydro-3(2 H)-pyridazinones[J]. Journal of Pharmaceutical Practice and Service, 2008, (3): 175-177,190.
shu

Synthesis and the antiplatelet aggregative activity of 4,5-dihydro-3(2 H)-pyridazinones

  • 1.

    No.85 Hospital of PLA,Shanghai,200052,China

  • 2.

    Department of Organnic Chemistry,School of Pharmcy,Second military Medical University,Shanghai,200433,China

  • Received Date: 2008-03-03
  • Objective: To study the antiplatelet aggregative activity of 6-(4-substituted acetamido-phenyl)-4,5-dihydro-3(2H)-pyridazinones inletting different piperazine groups. Methods: Ten target compounds were designed and synthesized.All of them were confirmed by 1H-NMR spectra.Born method was applied for preliminary pharmacological test in vitro. Results: All of the target compounds were reported.The results of preliminary pharmacological test showed that all the target compounds exhibited potent antiplatelet aggregative activity to a certain extent.Compound(1)/(4)and performed better than MCI-154 in vitro. Conclusion: The carbochain’s length of piperazine’s 4-substituted groups impacted the antiplatelet aggregative activity promintly.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2087) PDF downloads(419) Cited by()

Related
Proportional views

Synthesis and the antiplatelet aggregative activity of 4,5-dihydro-3(2 H)-pyridazinones

  • 1. No.85 Hospital of PLA,Shanghai,200052,China
  • 2. Department of Organnic Chemistry,School of Pharmcy,Second military Medical University,Shanghai,200433,China
  • Received Date: 2008-03-03

Abstract: Objective: To study the antiplatelet aggregative activity of 6-(4-substituted acetamido-phenyl)-4,5-dihydro-3(2H)-pyridazinones inletting different piperazine groups. Methods: Ten target compounds were designed and synthesized.All of them were confirmed by 1H-NMR spectra.Born method was applied for preliminary pharmacological test in vitro. Results: All of the target compounds were reported.The results of preliminary pharmacological test showed that all the target compounds exhibited potent antiplatelet aggregative activity to a certain extent.Compound(1)/(4)and performed better than MCI-154 in vitro. Conclusion: The carbochain’s length of piperazine’s 4-substituted groups impacted the antiplatelet aggregative activity promintly.

XU Yong, HUANG Xiao-jin, XU Jian-ming, CAI Ling-zhi, SONG Yan, ZHAO Qing-jie, Wu Qiu-ye. Synthesis and the antiplatelet aggregative activity of 4,5-dihydro-3(2 H)-pyridazinones[J]. Journal of Pharmaceutical Practice and Service, 2008, (3): 175-177,190.
Citation: XU Yong, HUANG Xiao-jin, XU Jian-ming, CAI Ling-zhi, SONG Yan, ZHAO Qing-jie, Wu Qiu-ye. Synthesis and the antiplatelet aggregative activity of 4,5-dihydro-3(2 H)-pyridazinones[J]. Journal of Pharmaceutical Practice and Service, 2008, (3): 175-177,190.
shu

    HTML

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return